Huadong Medicine Co., Ltd (SHE: 000963)
China flag China · Delayed Price · Currency is CNY
28.61
-0.11 (-0.38%)
Sep 9, 2024, 1:42 PM CST

Huadong Medicine Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Jun '24 Dec '23 Jan '23 Jan '22 Dec '20 Dec '19 2018 - 2014
Net Income
3,1012,8392,4992,3022,8202,813
Upgrade
Depreciation & Amortization
884.26795.45705.55591.56431404.48
Upgrade
Other Amortization
30.523.796.655.968.549.89
Upgrade
Loss (Gain) From Sale of Assets
-5.73-4.32-8.260.03-322.64-114.15
Upgrade
Asset Writedown & Restructuring Costs
25.0818.9-22.68.022.514.58
Upgrade
Loss (Gain) From Sale of Investments
86188.39115.6252.917.93-11.06
Upgrade
Provision & Write-off of Bad Debts
47.2725.7668.6941.6922.8328.58
Upgrade
Other Operating Activities
37.74121.32137.61132.51179.92209.98
Upgrade
Change in Accounts Receivable
-1,727-968.97-2,095-775.57-530.3-815.96
Upgrade
Change in Inventory
-405.52213.85-491.5218.09-37.73-159.6
Upgrade
Change in Accounts Payable
2,116685.551,450770.58797.16-368.87
Upgrade
Change in Other Net Operating Assets
53.543.017.24-4.9-
Upgrade
Operating Cash Flow
4,1833,9292,3823,1703,4112,002
Upgrade
Operating Cash Flow Growth
1.54%64.96%-24.86%-7.08%70.43%-1.85%
Upgrade
Capital Expenditures
-1,667-1,607-1,193-819.1-1,473-1,353
Upgrade
Sale of Property, Plant & Equipment
12.4610.8515.4379.16373.8157.93
Upgrade
Cash Acquisitions
-205.91-165.94-415.09-819.6--39.96
Upgrade
Divestitures
----113.37--
Upgrade
Investment in Securities
-211.5-115.24-948.91-357.5-629.8-256.94
Upgrade
Other Investing Activities
229.6126.4106.243.72-9.669.81
Upgrade
Investing Cash Flow
-1,842-1,751-2,436-1,987-1,739-1,583
Upgrade
Long-Term Debt Issued
-4,8764,9752,2592,2111,908
Upgrade
Total Debt Issued
5,3054,8764,9752,2592,2111,908
Upgrade
Long-Term Debt Repaid
--5,729-4,653-2,405-2,278-1,880
Upgrade
Total Debt Repaid
-5,111-5,729-4,653-2,405-2,278-1,880
Upgrade
Net Debt Issued (Repaid)
194.71-852.43322.13-146.03-67.2227.98
Upgrade
Issuance of Common Stock
10.6310.63104.65---
Upgrade
Common Dividends Paid
-1,069-594.21-576.49-460.11-565.73-570.63
Upgrade
Other Financing Activities
-88.2642.6650.01-161.31-92.78-65.95
Upgrade
Financing Cash Flow
-954.1-1,393-99.71-767.45-725.73-608.6
Upgrade
Foreign Exchange Rate Adjustments
-8.795.95-9.777.11-21.4422.57
Upgrade
Net Cash Flow
1,377791.25-163.23422.73925.64-166.94
Upgrade
Free Cash Flow
2,5162,3231,1892,3511,938648.25
Upgrade
Free Cash Flow Growth
-14.21%95.40%-49.43%21.26%199.03%-44.26%
Upgrade
Free Cash Flow Margin
6.11%5.72%3.15%6.80%5.76%1.83%
Upgrade
Free Cash Flow Per Share
1.441.330.681.341.110.37
Upgrade
Cash Interest Paid
--0.620.95--
Upgrade
Cash Income Tax Paid
2,6392,5523,0181,5392,1652,115
Upgrade
Levered Free Cash Flow
2,2521,905604.482,1041,160210.77
Upgrade
Unlevered Free Cash Flow
2,3241,977679.512,1471,203277.76
Upgrade
Change in Net Working Capital
-730.5-477.31811.18-614.8-340.75775.56
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.